CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection [NA]
Summary
Investigation of the Delve Detect cerebrospinal fluid metagenomic next-generation sequencing test for initial diagnostic workup in patients with suspected centr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Delve Bio, Inc. | Conditions: Central Nervous System Infection | NA | Status: NOT_YET_RECRUITING